The online version of this article (doi:10.1186/1477-7819-10-79) contains supplementary material, which is available to authorized users.
All authors declare that they have no competing interests.
IDC was the principle investigator who prepared, organized, and edited all aspects of the manuscript, and the surgeon who performed the operation. MM supported the work of the principle investigator in writing and editing the manuscript. AT supported the work of the principle investigator in writing and editing the manuscript. AA supported the work of the principle investigator in preparing the manuscript. AG was the pathologist who performed the pathological examination of the surgical specimen. GC supported the work of the principle investigator in preparing the manuscript. GB supported the work of the principle investigator in preparing the manuscript. All authors read and approved the final manuscript.
Alpha-fetoprotein (AFP) is an oncofetal protein produced by hepatocellular carcinoma (HCC). AFP level can also be elevated in other neoplastic or non-neoplastic conditions. An elevated AFP level has high diagnostic significance for HCC; at a level of >200 ng/mL, the probability of HCC is >90%. The aim of the present paper is to report a patient who underwent curative resection of HCC, who had a persistently elevated AFP level postoperatively but did not develop recurrence during a 2-year follow-up period. A review of the literature is also presented.
An 82-year-old male was referred following a computed tomography scan showing a 160 mm diameter mass in the left lobe of the liver. This huge mass was diagnosed as HCC, arising in the absence of cirrhosis or viral hepatitis. After tumor removal, the patient’s high AFP level persisted for 2 years.
As steatosis was the only pathological change in the remnant liver, this may have caused the persistently elevated AFP level in this patient.
Yokoi Y, Suzuki S, Baba SK, Inaba K, Konno H, Nakamura S: Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection. J Gastroenterol. 2005, 40: 274-282. 10.1007/s00535-004-1536-1. CrossRefPubMed
Sherman M: Current status of alpha-fetoprotein testing. Gastroenterol Hepatol (NY). 2011, 7: 113-114.
Arrieta O, Cacho B, Morales-Espinosa D, Ruelas Villavicencio A, Flores-Estrada D, Hernàndez-Pedro N: The progressive elevation of alpha-fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. BMC Cancer. 2007, 7: 28-10.1186/1471-2407-7-28. PubMedCentralCrossRefPubMed
Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreas Dis Int. 2008, 7: 237-757.
Shirabe K, Takenaka K, Gion T, Shimada M, Fujiwara Y, Sugimachi K: Significance of alpha-fetoprotein levels for detection of early recurrence of hepatocellular carcinoma after hepatic resection. J Surg Oncol. 1997, 64: 143-146. 10.1002/(SICI)1096-9098(199702)64:2<143::AID-JSO10>3.0.CO;2-7. CrossRefPubMed
Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, Xu W, Kan T: Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreas Dis Int. 2010, 9: 33-37.
Eleftheriou N, Heathcote J, Thomas HC, Sherlock S: Serum alpha-fetoprotein levels in patients with acute and chronic liver disease. Relation to hepatocellular regeneration and development of primary liver cell carcinoma. J Clin Pathol. 1977, 30: 704-708. 10.1136/jcp.30.8.704. PubMedCentralCrossRefPubMed
Van der Veek PP, de Vos Tot Nederveen Cappel WH, Langers AM, van Hoek B: Two patients with extremely elevated tumor markers: where is the malignancy?. Gastroenterol Res Pract. 2011, 123743: -
Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F: Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?. Am J Gastroenterol. 2006, 101: 524-532. 10.1111/j.1572-0241.2006.00443.x. CrossRefPubMed
Yao DF, Dong ZZ, Yao M: Specific molecular markers in hepatocellular carcinoma. Hepatobiliary Pancreas Dis Int. 2007, 6: 241-247.
Hsieh CB, Chen TW, Chu CM, Chu HC, Yu CP, Chung KP: Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?. World J Gatroenterol. 2010, 16: 3049-3055. 10.3748/wjg.v16.i24.3049. CrossRef
Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Chiu JH, Wu CW, P’eng FK: Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs’ A patients. J Surg Oncol. 1997, 66: 122-126. 10.1002/(SICI)1096-9098(199710)66:2<122::AID-JSO9>3.0.CO;2-F. CrossRefPubMed
Toonen F, Smilde T: A retroperitoneal mass with elevated alpha-1-fetoprotein: not always a testicular carcinoma. Neth J Med. 2010, 68: 33-34. PubMed
Schmoll HJ, Jordan K, Huddart R, Pes MP, Horwich A, Fizazi K, Kataja V: Testicular seminoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010, 21: 147-154. 10.1093/annonc/mdq177. CrossRef
Kanda T, Yoshida H, Mamada Y, Taniai N, Kawano Y, Mizuguchi Y, Shimizu T, Takahashi T, Ueda J, Kato S, Akimaru K, Tajiri T, Fukuda Y: Resection of liver metastases from an alpha-fetoprotein-producing gastric cancer. J Nihon Med Sch. 2005, 72: 66-70. 10.1272/jnms.72.66. CrossRef
Liu CZ, Hu SY, Wang L, Zhi XT, Jin B, Zhu M, Wachtel MS, Frezza EE: Hepatoid carcinoma of the pancreas: a case report. Chin Med J (Engl). 2007, 120: 1850-1852.
Perkins GL, Slater ED, Sanders GK, Prichard JG: Serum tumor markers. Am Fam Physician. 2003, 68: 1075-1082. PubMed
Babali A, Cakal E, Purnak T, Biyikoĝlu I, Cakal B, Yüksel O, Köklü S: Serum alpha-fetoprotein levels in liver steatosis. Hepatol Int. 2009, 10.1007/ s12072-009-9156-8. Nov 5
Chagas AL, Kikuchi LO, Oliveira JP, Vezozzo DC, Mello ES, Oliveira AC, Cella LC, Herman P, Bachella T, Caldwell SH, Alves VA, Carrilho FJ: Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?. Braz J Med Biol Res. 2009, 42: 958-962. 10.1590/S0100-879X2009005000019. CrossRefPubMed
Houwert AC, Giltay JC, Lentjes EG, Lock MT: Hereditary persistence of alpha-fetoprotein (HPAFP): review of the literature. Neth J Med. 2010, 68: 354-358. PubMed
No authors listed: Program of the annual meeting of the American Gastroenterology Association for the Study of Liver Diseases, and the Gastroenterology Study Group. Abstracts of Papers. Gastroenterology. 1979, 76: 1089-1316.
- Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature
Isidoro Di Carlo
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II